ARCHIVES

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998

Sentinel Node Disection No Worse Than Axillary

February 25, 2011

White House Order Poses Difficulties For NIH Peer Review

April 2, 1993

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

NCI Advisory Group, Other Cancer Meetings

April 29, 1983